NuView Life Sciences

Binary cancer diagnostics and theranostics,
improving patient outcomes and reducing healthcare costs.

NuView Life Sciences is working to improve the way cancer is diagnosed and treated for our modern healthcare system.

NuView Life Sciences is creating binary cancer diagnostics and Theranostics to improve patient outcomes and reducing healthcare costs.

Led by a multi-disciplinary team of industry experts with decades of combined experience in healthcare and medical imaging technologies, NuView Life Sciences is poised to change how we look for and respond to cancer.


NuView Life Sciences’s leading technology, NV-VPAC1TM consists of a series of peptide analogs that target the vasoactive intestinal peptide receptor type 1 (VPAC1). The VPAC1 receptor becomes overexpressed in certain key malignancies including breast, prostate, colon, bladder, and endometrial cancer.

In Vivo Diagnostics

a Positron Emission Tomography (PET) imaging agent for the in vivo diagnosis of breast and prostate cancer

In Vitro Diagnostics

an in vitro diagnostic kit that may be used for detecting shed prostate and bladder cancer cells in voided urine

Theranostics Applications

NuView is preparing to expand its portfolio for Theranostics applications using the NV-VPAC1TM peptide analog…

From the Press


NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment

The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford…

Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential

After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This could lead to a boom in cancer drugs that can…

Park City company develops new ground breaking cancer treatment

Park City company develops new ground breaking cancer treatment By Press Release August 25, 2020 283 0 Comments Park City— To meet the demand for…

Get Answers From the National Cancer Institute

Information specialists at NCI’s Cancer Information Service (CIS), NCI’s contact center, are available to help answer your cancer-related questions whether you are a patient, family member or friend, health care provider, or researcher. The service is available in English and Spanish.

We are proud to support the American Red Cross